Comparison of glutamate and N-methyl-D-aspartate toxicities on rat mesencephalic primary cell cultures

International Journal of Developmental Neuroscience

Volumn 15, Issue 7, 1997, Pages 851-865

  Mateu, Guylaine ^a   Privat, Alain ^a   Thibault, Jean ^b   Vignon, Jacques ^a  

^a INSTITUT CHARLES GERHARDT   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

Dopaminergic neurons; Excitotoxicity; Glutamate; N methyl D aspartate; Substantia nigra cell culture; TCP

Indexed keywords

EXCITOTOXIN; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEURON SPECIFIC ENOLASE; NEUROPROTECTIVE AGENT; TENOCYCLIDINE;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; EMBRYO; EMBRYO CELL; MESENCEPHALON; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALS; CELLS, CULTURED; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; LOGISTIC MODELS; N-METHYLASPARTATE; NEURONS; NEUROPROTECTIVE AGENTS; PHENCYCLIDINE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA;

EID: 0031576377     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(97)00038-5     Document Type: Article

References (44)

1. Beal, M. F., Mechanics of excitotoxicity in neurological diseases. FASEB J. 1992, 6, 3338-3344.
2. Bliss, T. V. P. and Collingridge, G. L., A synaptic model of memory : long-term potentiation in the hyppocampus. Nature, 1993, 361, 31-39.
3. Bridges, R. J., Hatalski, C. G., Shim, S. N., Cummings, B. J., Vijayan, V., Kundi, A. and Cotman, C. W., Gliotoxic actions of excitatory amino acids. Neuropharmacology, 1992, 31, 899-907.
4. Carlson, A., The current status of dopamine hypothesis of schizophrenia. Neuropsychopharmacology, 1988 1, 179-186.
5. Carlson, M. and Carlson, A., Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. TINS, 1990, 13, 272-276.
6. Casper, D. and Blum, M., Epidermal growth factor and basic fibroblast growth factor protect dopaminergic neurons from glutamate toxicity in culture. J.Neurochem., 1995, 65, 1016-1026.
7. Choi, D. W., Ionic dependence of glutamate neurotoxicity. J. Neurosci., 1987, 7, 369-379.
8. Choi, D. W., Glutamate neurotoxicity and diseases of the nervous system. Neuron, 1988, 1, 623-234.
9. Choi, D. W., Glutamate receptors and the induction of excitotoxic neuronal death. In Neurosciences : From the Molecular to the Cognitive. Progress in Brain Research, Vol 100, ed. F. Bloom, pp. 47-51. Elsevier Science, Amsterdam. 1994.
10. Christoffersen, C. L. and Meltzer, L. T., Evidence for N-methyl-D-aspartate and AMPA subtypes of glutamate receptors on substantia nigra dopamine neurons : possible preferential role for N-Methyl-D-aspartate receptors. Neuroscience, 1995, 67, 373-381.
11. Drian M.-J., Kamenka J.-M., Pirat J.-L., Privat A. J.Neurosci. Res., 1991, 29:1991;133.
12. Driscoll, B. F., Deibler, G. E., Law, M. J. and Crane, A. N., Damage to neurons in culture following medium change : role of glutamine and extracellular generation of glutamate. J. Neurochem. 1993, 61, 1795-1800.
13. Driscoll, B. F., Law, M. J. and Crane, A. N., Cell damage associated with changing the medium of mesencephalic cultures in serum-free medium is mediated via N-methyl-D-aspartate receptors. J. Neurochem., 1991, 56, 1201-1206.
14. Farooqui, A. A. and Horrocks, L. A., Excitatory amino acid receptors, neural membrane phospholipid metabolism and neurological disorders. Brain Res. Rev., 1991, 16, 171-191.
15. Fonnum, F., Glutamate : a neurotransmitter in mammalian brain. J.Neurochem., 1984, 42, 1-11.
16. Gallo, V. and Russel, J. T., Excitatory amino acid receptors in glia : different subtypes for distinct functions? J. Neurosci. Res., 1995, 42, 1-8.
17. Giffard,R. G., Monyer, H., Christine, C. W. and Choi, D. W., Acidosis reduces NMDA receptor activation, glutamate neurotoxicity, and oxygen-glucose deprivation neuronal injury in cortical cultures. Brain Res., 1990, 506, 339-342.
18. Hollman, M. and Heinemann, S., Cloned glutamate receptors. Ann. Rev. Neurosci., 1994, 17, 31-108.
19. Jones, M. V. and Westbrook, G. L., The impact of receptor desensitization on fast synaptic transmission. TINS, 1991, 19, 96-101.
20. Johnson, S. W., Seutin, V. and North, R. A., Burst firing in dopamine neurons induced by N-methyl-D-aspartate : role of electrogenic Sodium pump. Science, 1992, 285, 665-667.
21. Kikuchi, S. and Kim, S. U., Glutamate neurotoxicity in mesencephalic dopaminergic neurons in culture. J. Neurosci. Res., 1993, 36, 558-569.
22. Koh, J. Y. and Choi, D. W., Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Meth., 1987, 20, 83-90.
23. Lehmann, A. and Hansson, E., Morphological effects of excitatory amino acid analogs on primary astroglial cultures. Neurochem. Int., 1988, 13, 105-110.
24. Levallois, C., Calvet, M. C., Kamenka, J.-M. and Petite, D., TCP promotes the survival of human spinal cord neurons in culture. In Multiple Sigma and PCP Receptor Ligands : Mechanisms for Neuromodulation and Neuroprotection? ed. J.-M. Kamenka and E. F. Domino, pp. 895-901. NPP Books, Ann Arbor, 1992.
25. Levallois, C., Petite, D., Tsiang, H., Kamenka, J.-M. and Privat, A., Non competitive antagonists of NMDA protect cultured rat cortical neurons against the toxicity of gp 160, a HIV coat glycoprotein. In Multiple Sigma and PCP Receptor Ligands : Mechanisms for Neuromodulation and Neuroprotection? ed. J.-M, Kamenka and E. F. Domino, pp. 903-910. NPP Books, Ann Arbor, 1992.
26. Lockhart, B. P., Vila, J., Hamedi-Sangsari, F. H., Privat, A. and Vignon, T., Neurotoxic effect of the anti-HIV drug D-aspartate β-hydroxamate for rat primary neuronal cultures : attenuation by N-methyl-D-Aspartate (NMDA) antagonists. Brain Res., 1993, 630, 32-40.
27. Malenka, R. C. and Nicoll, R. A., NMDA-receptor-dependent plasticity : multiple forms and mechanisms. TINS, 1993, 16, 521-527.
28. Marey-Semper, I., Gelman, M. and Levi-Strauss, M., A selective toxicity toward cultured mesencephalic dopaminergic neurons is induced by the synergistic effects of energetic metabolism impairment and NMDA receptor activation. J. Neurosci., 1995, 15, 5912-5918.
29. McEntee, W. J. and Crook, R. H., Glutamate : its role in learning, memory, and the aging brain. Psychopharmacology, 1993, 111, 391-401.
30. Meldrum, B. and Garthwaite, J., Excitatory amino acid neurotoxicity and neurodegenerative disease. TIPS, 1990, 11, 379-387.
31. Mereu, G., Costa, E., Armstrong, D. M. and Vicini, S., Glutamate receptor subtypes mediate excitatory synaptic currents of dopamine neurons in midbrain slices. J. Neurosci., 1991, 11, 1359-1365.
32. Michel, P. P. and Agid, Y., The glutamate antagonist, MK801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyrinium ion (MPP+) in rat dissociated mesencephalic cultures. BrainRes., 1992, 597, 233-240.
33. Monogham, D. T., The excitatory amino acid receptors : their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu. Rev. Pharmacol. Toxicol., 1989, 29, 365-402.
34. Nakanishi, S., Molecular diversity of glutamate receptors and implications for brain function. Science, 1992, 258, 597-603.
35. Olney, J. W., Excitotoxic amino acids and neuropsychiatric disorders. Annu. Rev. Pharmacol. Toxicol., 1990, 30, 47-71.
36. Olney, J. W., Excitotoxicity and neuropsychiatric disorders. In Glutamate, Cell Death and Memory, ed. P. Ascher, D. W. Choi and Y. Christen, pp. 77-101. Springer-Verlag, Berlin Heidelberg, 1991.
37. Ossowska, K., The role of excitatory amino acids in experimental models of Parkinson's disease. J. Neural Transm., 1994, 8, 39-71.
38. Pin, J. P. and Duvoisin, R., The metabotropic glutamate receptors : structure and functions. Neuropharmacology, 1995, 34, 1-26.
39. Rondoin,G., Drian, M.-J., Chicheportiche, R., Kamenka, J.-M. and Privat, A., Non-competitive antagonists of N-methyl-D-aspartate receptors protect cortical and hippocampal cell cultures against glutamate neurotoxicity. Neurosci. Lett., 1988, 91, 199-203.
40. Rosenberg, P. A. and Aizenman, E., Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex. Neurosci. Lett., 1989, 103, 162-168.
41. Rosenberg, P. P., Amin, S. and Leitner, M., Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture. J.Neurosci., 1992, 12, 56-61.
42. Teichberg, V. I., Glial glutamate receptors : likely actors in brain signalling. FASEB J., 1991, 5, 3086-3091.
43. Thibault, J., Vidal, D. and Cros, F., Invitro translation of mRNA from rat pheochromocytoma tumors. Characterization of tyrosine hydroxylase. Biochem. Biophys. Res. Commun., 1981, 99, 960-968.
44. Weller, M., Finiels-Marlier, F. and Paul S. M., NMDA receptors-mediated glutamate toxicity of cultured cerebellar, cortical and mesencephalic neurons : neuroprotective properties of amantadine and memantine. Brain Res., 1993, 613, 143-148.